Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)
Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%), a configuration of Zeng et al. 2026 cfMeDIP-seq PCA classification workflow: 5' end-motif, fragment-ratio and methylation PCs each contributing >1% of variance from cfMeDIP-seq reads.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Model Capabilities & Hardware Requirements
Deployment facts recorded for Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%). Fields the record does not carry are marked not recorded.
Evaluations and results
2 evaluations · 4 results. Different protocols are not a single leaderboard.
Sorted by AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Protocol and dataset | AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) | AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models) | Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) | Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models) |
|---|---|---|---|---|---|
| Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)Evaluation | Zeng et al. 2026 independent PE validation dataset: cancer vs healthy, Zeng et al. 2026 independent paired-end validation dataset | 0.514 | Not reported | 0.317 | Not reported |
| Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)Evaluation | Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation, Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples) | Not reported | 0.974 | Not reported | 0.896 |
All 4 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%) | Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples) | 0.974 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0242400530902103. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation + Ratios (1%) on pe primary cv (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-primary-cv Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_auc' |
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%) | Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples) | 0.896 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0857671794470052 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation + Ratios (1%) on pe primary cv (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-primary-cv Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_sens99' |
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.514 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0760470615897827. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation + Ratios (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_auc' |
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.317 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0833539069253844 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation + Ratios (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 7 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_sens99' |
Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.
Use this configuration
How it works, versions and access
Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
2 source records and release history
- A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection · Original source · Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
- Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Original source · 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID ctdnalit-20261011-zeng2026-config-motif-methylation-ratios-1pct.
Source locator: Source Data Fig. 4 row labels; Results P29-P33; Methods P59
How to cite
Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%). Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/ctdnalit-20261011-zeng2026-config-motif-methylation-ratios-1pct/
Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.
The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence